Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.

Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.
复制标题

DOI:
10.1111/j.1471-4159.2011.07565.x
复制
发表时间:
2012-02
影响因子:
4.7
通讯作者:
Banerjee P
Banerjee P
中科院分区:
医学2区
文献类型:
--
作者:
Purkayastha S;Ford J;Kanjilal B;Diallo S;Del Rosario Inigo J;Neuwirth L;El Idrissi A;Ahmed Z;Wieraszko A;Azmitia EC;Banerjee P

文献摘要

参考文献

被引文献

相似文献

前额叶皮层(PFC)中多巴胺的异常释放被认为是精神分裂症的基础,但广泛使用的抗精神病药氯氮平(Clz)引起神经递质释放电刺激的机制途径尚不清楚。我们分析了Clz诱发的调节PFC中的神经元活动,刺激轴突在第IV和V层,并记录在突触后锥体细胞的第II和III层的电效应。我们观察到Clz诱发的群体峰电位(PS)增加,这是由5-羟色胺1A受体(5-HT 1A-R)、磷脂酶Cβ和Ca 2 +/钙调蛋白依赖性蛋白激酶II(CaMK II)介导的。免疫印迹表明,Clz激活的CaMK Ⅱ是5-HT 1A-R介导的。有趣的是,N-甲基-D-天冬氨酸受体(NMDA-R)拮抗剂(±)2-氨基-5-膦酰基戊酸(APV)消除了Clz介导的PS增加,表明5-HT 1A-R、NMDA-R和CaMK II形成协同三联体,其增强兴奋性突触后电位(EPSP),从而增强PS。在证实,Clz以及NMDA增强场EPSP(fEPSP),WAY 100635(5-HT 1A-R拮抗剂),APV,和CaMK Ⅱ抑制剂消除这种增加。如前所述,CaMKII与NMDA-R NR 2B亚基结合,变得具有组成性活性,从而诱导α-氨基-3-羟基-5-甲基-4-异恶唑丙酸酯(AMPA)受体募集至突触后膜,并增加fEPSP。免疫共沉淀表明,Clz可能在突触后密度的膜筏中增强CaMKII、NR 2B和5-HT 1A-R之间的相互作用,因为用甲基-β-环糊精(一种破坏筏的试剂)预处理抑制了免疫共沉淀和fEPSP。总之,氯氮平通过协调5-HT 1A-R、CaMKII和NMDA-R之间的协同作用在PFC中发挥作用,这增强了PFC第II/III层神经元的兴奋性。
Aberrant dopamine release in the prefrontal cortex (PFC) is believed to underlie schizophrenia, but the mechanistic pathway through which a widely used antipsychotic, clozapine (Clz), evokes neurotransmitter-releasing electrical stimulation is unclear. We analyzed Clz-evoked regulation of neuronal activity in the PFC by stimulating axons in layers IV and V and recording the electrical effect in the postsynaptic pyramidal cells of layers II and III. We observed a Clz-evoked increase in population spike (PS), which was mediated by serotonin 1A receptor (5-HT1A-R), phospholipase Cβ, and Ca2+/calmodulin-dependent protein kinase II (CaMKII). Immunoblotting demonstrated that the Clz-activation of CaMKII was 5-HT1A-R-mediated. Intriguingly, the N-methyl-D-aspartic acid receptor (NMDA-R) antagonist (±)2-Amino-5-phosphonovaleric acid (APV) eliminated the Clz-mediated increase in PS, suggesting that the 5-HT1A-R, NMDA-R and CaMKII form a synergistic triad, which boosts excitatory post-synaptic potential (EPSP), thereby enhancing PS. In corroboration, Clz as well as NMDA augmented field EPSP (fEPSP), and WAY100635 (a 5-HT1A-R antagonist), APV, and a CaMKII inhibitor eliminated this increase. As previously shown, CaMKII binds to the NMDA-R NR2B subunit to become constitutively active, thereby inducing α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor recruitment to the postsynaptic membrane and an increase in fEPSP. Coimmunoprecipitation demonstrated that Clz potentiates interactions among CaMKII, NR2B, and 5-HT1A-R, possibly in the membrane rafts of the postsynaptic density, because pretreatment with methyl-ß-cyclodextrin, an agent that disrupts rafts, inhibited both coimmunoprecipitation as well as fEPSP. In summary, clozapine functions in the PFC by orchestrating a synergism among 5-HT1A-R, CaMKII, and NMDA-R, which augments excitability in the PFC neurons of layers II/III.
DOI: 10.1523/jneurosci.2999-05.2005
发表时间: 2005-11-23
影响因子: 5.3
作者:
Díaz-Mataix, L;Scorza, MC;Artigas, F
通讯作者: Artigas, F
DOI: 10.1111/j.1460-9568.2004.03805.x
发表时间: 2004-12-01
影响因子: 3.4
作者:
Auclair, A;Drouin, C;Tassin, JP
通讯作者: Tassin, JP
DOI: 10.1016/0014-2999(95)00234-c
发表时间: 1995-07-25
影响因子: 5
作者:
FORSTER, EA;CLIFFE, IA;FLETCHER, A
通讯作者: FLETCHER, A
DOI: 10.1007/s007020050093
发表时间: 1998-01-01
影响因子: 3.3
作者:
Broderick, PA;Piercey, MF
通讯作者: Piercey, MF
DOI: 10.1016/0304-3940(80)90178-0
发表时间: 1980-01-01
影响因子: 2.5
作者:
KIM, JS;KORNHUBER, HH;HOLZMULLER, B
通讯作者: HOLZMULLER, B